tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Grail and Samsung partner to bring Grail’s Galleri cancer test to Asia
PremiumThe FlyGrail and Samsung partner to bring Grail’s Galleri cancer test to Asia
4d ago
Grail price target raised to $75 from $43 at Canaccord
Premium
The Fly
Grail price target raised to $75 from $43 at Canaccord
17d ago
Craig-Hallum healthcare/pharma analysts hold analyst/industry conference call
Premium
The Fly
Craig-Hallum healthcare/pharma analysts hold analyst/industry conference call
27d ago
PremiumRatingsGRAIL Inc. Hold Rating: Balancing Promising Long-Term Prospects with Near-Term Uncertainties
2M ago
Premium
Company Announcements
GRAIL Reports Growth in Galleri Test Revenue
2M ago
Grail reports Q2 EPS ($3.18), consensus ($3.56)
Premium
The Fly
Grail reports Q2 EPS ($3.18), consensus ($3.56)
2M ago
PremiumCompany AnnouncementsGrail Inc.’s REACH Study: Advancing Multi-Cancer Detection in Medicare
4M ago
Grail assumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Grail assumed with an Equal Weight at Morgan Stanley
4M ago
Premium
Ratings
Cautious Optimism for GRAIL Inc: Hold Rating Amid Early Market Position and Future Milestones
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100